Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.
scientific article published on 6 January 2017
Author/s
author: Raphaël Gaillard, Cristina Bulai Livideanu, Carle Paul, Ewa Jassem, Marek Niedoszytko, Srdan Verstovsek, Patrice Dubreuil, Olivier Hermine, Olivier Lortholary, Ludovic Lhermitte, Danielle Canioni, Gandhi Damaj
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.